Literature DB >> 22249528

Antiarrhythmic drug therapy for atrial fibrillation.

Peter Zimetbaum1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22249528     DOI： 10.1161/CIRCULATIONAHA.111.019927

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  61 in total

Review 1.  Antiarrhythmic therapy as an adjuvant to promote post pulmonary vein isolation success-a meta-analysis.

Authors:  Gustavo R Goldenberg; Daniel Burd; Piotr Lodzinski; Giuseppe Stabile; Jacob A Udell; David Newman; Mohammed Shurrab; Eugene Crystal
Journal:  J Interv Card Electrophysiol       Date:  2016-06-29       Impact factor: 1.900

Review 2.  Atrial Fibrillation in the ICU.

Authors:  Nicholas A Bosch; Jonathan Cimini; Allan J Walkey
Journal:  Chest       Date:  2018-04-06       Impact factor: 9.410

3.  Pleiotropic actions of amiodarone: still puzzling after half a century.

Authors:  Jordi Heijman; Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-09       Impact factor: 3.000

4.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

Review 5.  [Cardiovascular pharmacotherapy. Risks and adverse effects].

Authors:  N Voigt; J Heijman; D Dobrev
Journal:  Herz       Date:  2014-03       Impact factor: 1.443

6.  2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry.

Authors:  Jonathan S Steinberg; Niraj Varma; Iwona Cygankiewicz; Peter Aziz; Paweł Balsam; Adrian Baranchuk; Daniel J Cantillon; Polychronis Dilaveris; Sergio J Dubner; Nabil El-Sherif; Jaroslaw Krol; Malgorzata Kurpesa; Maria Teresa La Rovere; Suave S Lobodzinski; Emanuela T Locati; Suneet Mittal; Brian Olshansky; Ewa Piotrowicz; Leslie Saxon; Peter H Stone; Larisa Tereshchenko; Mintu P Turakhia; Gioia Turitto; Neil J Wimmer; Richard L Verrier; Wojciech Zareba; Ryszard Piotrowicz
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-05       Impact factor: 1.468

7.  Conversion of Recent-Onset Atrial Fibrillation: Which Drug is the Best?

Authors:  Diego Conde; Pablo Elissamburu; Nicolas Lalor; Leandro Rodriguez; Martin Aragon; Juan Pablo Costabel; Florencia Lambardi; Marcelo Trivi
Journal:  J Atr Fibrillation       Date:  2013-08-31

Review 8.  Prophylactic Antiarrhythmic Drug Therapy in Atrial Fibrillation.

Authors:  Moisés Rodríguez-Mañero; Andrea Sarkozy; Gian-Battista Chierchia; Rubén Casado-Arroyo; Danilo Ricciardi; Carlo de Asmundis; Andrea Carlo de; Pedro Sarkozy
Journal:  J Atr Fibrillation       Date:  2013-02-12

9.  Discovery of 5-Phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine as a Potent I Kur Inhibitor.

Authors:  Heather J Finlay; James A Johnson; John L Lloyd; Ji Jiang; James Neels; Prashantha Gunaga; Abhisek Banerjee; Naveen Dhondi; Anjaneya Chimalakonda; Sandhya Mandlekar; Mary Lee Conder; Harinath Sale; Dezhi Xing; Paul Levesque; Ruth R Wexler
Journal:  ACS Med Chem Lett       Date:  2016-06-09       Impact factor: 4.345

10.  [Medicinal rhythm control in atrial fibrillation].

Authors:  Bernd Nowak; Alexander Fürnkranz
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2014-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.